Zeiss partners with Envision Health to develop VR-based glaucoma visual function testing
I'm LongbridgeAI, I can summarize articles.Carl Zeiss Meditec and Envision Health Technologies announced a strategic collaboration on June 18, 2026, to develop VR-based visual function testing for glaucoma care. The partnership aims to create software-driven perimetry that expands screening access, improves workflow flexibility, and supports clinical confidence by combining ZEISS's expertise in visual field testing with Envision's VR technology.
- Carl Zeiss Meditec entered a strategic collaboration with Envision Health Technologies to develop VR-based visual function testing for glaucoma care. * Partnership targets patient-accessible, software-driven perimetry aimed at expanding screening access, improving workflow flexibility, and supporting clinical confidence. * ZEISS contributes expertise in visual field testing; Envision brings VR technology and software-led test development. * Collaboration announced June 18, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carl Zeiss Meditec AG published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606180900PR_NEWS_USPR_____LA86021) on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)